CITATION: Moyo, S. et al. 2015. Identifying recent HIV infections : from serological assays to genomics. Viruses, 7(10):5508-5524, doi:10.3390/v7102887.The original publication is available at http://www.mdpi.com/journal/virusesIn this paper, we review serological and molecular based methods to identify HIV infection recency. The accurate identification of recent HIV infection continues to be an important research area and has implications for HIV prevention and treatment interventions. Longitudinal cohorts that follow HIV negative individuals over time are the current gold standard approach, but they are logistically challenging, time consuming and an expensive enterprise. Methods that utilize cross-sectional testing and biomarker informat...
Background HIV-1 genetic diversity increases during infection and can help infer the time elapsed si...
ABSTRACT: BACKGROUND: Serologic testing algorithms for recent HIV seroconversion (STARHS) provide i...
OBJECTIVE:HIV seroconversion biomarkers are being used in cross-sectional studies for HIV incidence ...
In this paper, we review serological and molecular based methods to identify HIV infection recency. ...
The study investigates a pattern-based method for measuring intra-patient viral genetic diversity fo...
BACKGROUND: Assays and multi-assay algorithms (MAAs) have been developed for population-level cross-...
Background Cross-sectional, biomarker methods to determine HIV infection recency present a promisin...
CITATION: Seaton, K. E., et al. 2018. Computational analysis of antibody dynamics identifies recent ...
Record numbers of new diagnoses of HIV infection have been recorded in the UK in recent years. Howev...
Background: Cross-sectional, biomarker methods to determine HIV infection recency present a promisin...
Detection of recent HIV infections is a prerequisite for reliable estimations of transmitted HIV dru...
BACKGROUND:Cross-sectional, biomarker methods to determine HIV infection recency present a promising...
We systematically reviewed the accuracy of serological tests for recent infections with HIV that hav...
In 2011, there were over 34 million people living with HIV infections, placing a heavy burden on pub...
BACKGROUND: Knowledge of the number of recent HIV infections is important for epidemiologic surveill...
Background HIV-1 genetic diversity increases during infection and can help infer the time elapsed si...
ABSTRACT: BACKGROUND: Serologic testing algorithms for recent HIV seroconversion (STARHS) provide i...
OBJECTIVE:HIV seroconversion biomarkers are being used in cross-sectional studies for HIV incidence ...
In this paper, we review serological and molecular based methods to identify HIV infection recency. ...
The study investigates a pattern-based method for measuring intra-patient viral genetic diversity fo...
BACKGROUND: Assays and multi-assay algorithms (MAAs) have been developed for population-level cross-...
Background Cross-sectional, biomarker methods to determine HIV infection recency present a promisin...
CITATION: Seaton, K. E., et al. 2018. Computational analysis of antibody dynamics identifies recent ...
Record numbers of new diagnoses of HIV infection have been recorded in the UK in recent years. Howev...
Background: Cross-sectional, biomarker methods to determine HIV infection recency present a promisin...
Detection of recent HIV infections is a prerequisite for reliable estimations of transmitted HIV dru...
BACKGROUND:Cross-sectional, biomarker methods to determine HIV infection recency present a promising...
We systematically reviewed the accuracy of serological tests for recent infections with HIV that hav...
In 2011, there were over 34 million people living with HIV infections, placing a heavy burden on pub...
BACKGROUND: Knowledge of the number of recent HIV infections is important for epidemiologic surveill...
Background HIV-1 genetic diversity increases during infection and can help infer the time elapsed si...
ABSTRACT: BACKGROUND: Serologic testing algorithms for recent HIV seroconversion (STARHS) provide i...
OBJECTIVE:HIV seroconversion biomarkers are being used in cross-sectional studies for HIV incidence ...